Abstract Intercellular communication mediated by exosomes, nano-sized extracellular vesicles, is crucial for preserving vascular integrity and in the development of cardiovascular and other diseases. As natural carriers of signal molecules, exosomes released from sources such as blood cells, endothelial cells, immune cells, smooth muscle cells, etc., can modify a multitude of cellular bioactivities. They do so by shuttling lipids, proteins, and nucleic acids between donor and recipient cells while circulating in body fluids and in the extracellular space. A recent surge of interest in the field of exosomal biology is in part due to the recognition that the molecules they carry can act as facilitators of both pathogenesis but can also initiate protective and rescue signaling. This mini-review describes current knowledge on exosome function in health and disease including cardiovascular disease.
Introduction
Notice the small things: The rewards are inversely proportional -Liz Vassey Cell-derived nano-sized (30-100 nm) vesicles termed exosomes are continuously released from most cell types and have been identified in all biological fluids and in the medium of cultured cells in vitro.
Intercellular communication mediated by extracellular vesicles is crucial for preserving vascular integrity and in the development of cardiovascular and other diseases. As natural carriers of signal molecules, exosomes released from sources such as blood cells, endothelial cells, immune cells, smooth muscle cells, etc., can modify a multitude of cellular bioactivities. They do so by shuttling lipids, proteins, and nucleic acids between donor and recipient cells while circulating in body fluids and in the extracellular space. A recent surge of interest in the field of exosomal biology is in part due to the recognition that the molecules they carry can act as facilitators of both pathogenesis but can also initiate protective and rescue signaling. Exosomes have been described to modulate immuneregulatory processes and tumor escape mechanisms and to mediate both regenerative and degenerative processes.
To date, a large number of reports dealing with circulating exosomes and their cargos define them to be a potential source of valuable diagnostic and prognostic biomarkers and hold a great therapeutic potential to serve as vehicles for targeted therapy for cardiovascular and other diseases.
Biogenesis of Exosomes and Sorting of Cargo
While other microparticles such as apoptotic bodies and microvesicles form through blebbing of dying cells and outward budding of plasma membrane, respectively, exosomes are unique in their biogenesis and release. Exosomes are formed through the inward budding of endosomal membranes in areas particularly enriched in lipid rafts. Formation and secretion of such vesicles require enzymes and ATP and can be both endosomal sorting complexes required for transport (ESCRT) dependent and independent [1] [2] [3] . They accumulate and are enriched in endosomes called multivesicular bodies (MVBs), from which they are released into extracellular space and are taken up by neighboring cells or transported through body fluids to remote locations. They contain lipids, proteins, and various types of nucleic acids such as mRNA, miRNA, and lncRNA. Beside the molecular components involved in exosome generation, secretion, transport, and uptake common to all exosomes such as tetraspanins (CD9, CD63, CD81), membrane proteins Annexins and Flotillin, and heat shock proteins HSP70 and HSP90 [4] , exosomes also contain unique molecules specific to their cells of origin. It is this type, variety, and abundance of donor cell-specific cargo that is a topic of extensive studies, in hopes to shed light on their potential application for the development of diagnostic and therapeutic tools. The exact pathways which regulate the packing of exosomal content do not appear to be a random collection of cytoplasmic proteins and nucleic acids from donor cells. Valadi et al. 2007 [5] identified many exosomal components not expressed in the cytoplasm of donor cells, indicating a highly regulated and selective cargo sorting mechanism that delivers and guides specific intracellular miRNAs into exosomes [6] . Similar conclusions were made based on the observation that miRNA profiles of exosomes and their parent cells can significantly differ from one another [7, 8] . Interestingly, the profiles of exosomes from same cell types can be significantly altered based on the cell's physiological state during synthesis. The quantity and quality of constitutively secreted exosomes are regulated by the physiology of the donor cells as well as by stimuli such as calcium, mitogens, cytokines, and stress [9] . A new online database, ExoCarta [10] , has been established and provides a continuously growing list of molecules identified in exosomes.
Transport and Targeting
Detailed mechanisms of exosome trafficking, to near and far destinations, targeting to specific organs, tissues, and cells as well as the modes of internalization, are still not well understood. It is known that secreted exosomes can either be rapidly internalized by neighboring cells or travel via body fluids to deliver their informational cargo to distant cells or possibly remove it from the organism. Despite the lack of knowledge of detailed mechanisms concerning exosomal interaction with target cells, some reports suggest that lipid rafts and exosomal membrane proteins are directly responsible for their trafficking and mode of interaction with cells and dictate their uptake specificity. This is evidenced by reports that the disruption of lipid rafts, annexins, or in general any treatment of exosomes to interfere with their transmembrane receptors results in uptake inhibition. Suggested pathways of exosome trafficking and routes and dynamics of exosome-cargo internalization has been extensively reviewed in [11, 12] .
Emerging evidence suggests that exosomes released from cells are exploited as natural vehicles for the delivery of membrane-tethered signaling molecules and membraneenclosed nucleic acids. They have been shown to be instrumental in modulating the environment and function of targeted cells. Increased interest in the exosomal cargo studies, especially the miRNA, has uncovered their important role in modulating of genetic exchange between cells and modification of cellular function. Thus, they are investigated for the role they play in physiology and pathology of cancers, neurodegenerative and autoimmune disorders, immune responses, and cardiovascular pathologies (Fig. 1) .
Recent studies emphasize the importance of exosomebased communication within the cardiovascular system [13] , especially between stem and cardiac cells and the exchange between the heart and the bone marrow compartments (Table  1 ) [14] [15] [16] .
Isolation
Isolation and purification of exosomes for both characterization and diagnostics as well as for therapeutic purposes have not been without controversy. Given the small size of the vesicles, which lie below the resolution threshold of light imaging and flow cytometry detection, indirect characterization, albeit not quantitative, has to be employed. They can be enriched and identified with antibodies specific to exosomal membrane markers [4] . Furthermore, electron microscopy can be used to visualize and identify exosomes based on their relative size and morphology. Dynamic light scattering (DLS) method can Fig. 1 Exosomes impact the physiology of the cells, tissues, and organs: exosomes carry and deliver messenger RNAs (mRNAs), noncoding RNA (nCRNAs), proteins, lipids, and participate in cellular functions viz., cell adhesion, extracellular matrix (ECM) modulation, electrical response, apoptosis, angiogenesis, and development be used as it determines the scatter of laser light passing through the sample. Other approaches, aimed at quantifying exosomes, such as protein concentration measurements are indirect approximations at best, considering that the range of sizes and cargo load can differ substantially based on a multitude of parameters. Isolation techniques for obtaining a pure exosome preparation are based on their unique size and density, distinguishing them from other circulating particles. They mostly involve sequential high-velocity centrifugations and gradient separations as well as antibody capture and chemical precipitation. Additionally, affinity and size exclusion chromatography have also found their applications [17] [18] [19] .
Use of Exosomes/Applications Biomarkers
Due to their ability to circulate freely in all biological fluids of the body and provide a protective shuttle mechanism for their cargo, exosomes can be collected non-invasively and with minimal risk to patients. As their cargo has been described to differ between different physiological and pathological conditions, their composition can be assessed for identification as potential disease-related biomarkers. Their unique pathological signatures have already been identified for numerous cancers and neuropathologies such as prostate [20] , ovarian [21] , and colorectal cancer [22, 23] and Alzheimer's disease [24] . Even though it is unlikely that a single biomarker will be identified to diagnose myocardial ischemia and or necrosis, circulating miRNA profiles seem to be altered in cardiovascular pathologies, holding promise for early detection and successful intervention [25] [26] [27] [28] [29] .
Therapeutics
Among other exosomal cargo constituents, mRNA and miRNA have been shown to effectively regulate/ influence the gene expression and physiology of targeted cells. miRNAs play a pivotal role in cell proliferation, differentiation, and apoptosis as well as their pathological dysregulations. Despite the progress in the efficient delivery of miRNAs as gene therapy agents, miRNAs have a very short half-life in circulation and are very susceptible to degradation. However, miRNAs contained in exosomes have a significantly extended shelf life, are protected from enzymatic degradation, and can be delivered to target cells without the loss of activity. Cell-based therapy for cardiovascular disorders experiences only limited success due to cell retention and engraftment issues as well as potential immunogenicity. Exosome-based treatment options, however, provide cell-free therapeutic candidates that offer to provide comparable benefits. One of the most active areas of translational research is to identify the most effective cell type and environment for generation of most effective cardio-protective and cardio-regenerative exosomes [15, 30, 31] .
Vehicles for Drug Delivery
Unlike stem cell-based therapy, application of engineered exosomes with defined targets and cargos promises a more efficient and direct method of gene therapy delivery. Following the natural path of exosome biogenesis and [ 56] targeted transport, it is feasible to assume that certain stimuli could activate cells to manufacture exosomes beneficial for a range of therapeutic applications. Thus, strides are being made to manipulate exosome-producing donor cells in order to enhance their beneficial characteristics. Engineering of custom exosomes can be achieved indirectly by cell manipulations through stress such as hypoxic preconditioning [15] , genetic modifications [32] , and epigenetic reprogramming [33] or by transducing donor cells with appropriate vectors to make them stably overexpressed and package the intended cargo. Additionally, a direct route of cargo packaging can be used by transfecting or electroporating exosomes with the desired molecular candidates. Regardless of their natural or engineered origin, exosome-based therapeutics can be introduced through intravenous and intraperitoneal injections or through local intra-tissue injections for delivery of targeted therapy [1, 34, 35] .
Exosomes in Cardiovascular Health and Disease
Intercellular communication mediated by extracellular vesicles is crucial for preserving vascular integrity and in the development of cardiovascular and other diseases. In cancer, exosomes have been described to possess the ability to pass on malignancy from cell to cell and shape the environment by stimulating blood vessel formation, while concomitantly inhibiting immune response to the tumor [36] [37] [38] . Similarly, they have also been shown to shuttle viral particles from cell to cell (Fig. 2) [39, 40] . In recent years, many published reports suggest that in addition to cancers and neurodegenerative disorders, major cardiovascular and metabolic pathologies like coronary artery disease, myocardial infarction, heart failure, and diabetes are highly influenced by the exosome-directed transfer of molecules. It has been demonstrated that exosomally delivered mRNAs and miRNAs are translated and regulate gene expression of acceptor cells influencing their biology. They contribute to the maintenance of cardiovascular and arterial homeostasis as well as their pathologies and play a functionally significant role in processes such as immune response, tumor progression, proliferation, and apoptosis [5, [41] [42] [43] .
A continuously growing body of evidence implicates exosome-delivered miRNA cargo as major contributors to both the maintenance of cardiovascular and arterial homeostases as well as progression of pathologies due to their regulatory role in gene expression. Their varied cargos depend on the cells of origin and the microenvironmental stimuli which act upon them. Among a long list of investigated miRNAs and their targets thus far (which have been reviewed more extensively in other publications [44] [45] [46] ), some show modified expression and or activity based on the pathophysiological conditions.
During coronary artery disease, under pro-inflammatory conditions such as atherosclerosis, exosomes derived from vascular endothelial cells, smooth muscle cells, macrophages, and other circulating immune cells contribute to communication of the status of inflammation [44, 47, 48] possibly directing cellular responses to a changing environment. Rautou et al. 2011 describes a correlation between exosomes released from atherosclerotic plaques and stimulation of endothelial cell proliferation, increased adhesion molecule expression, and inflammatory cell recruitment, leading promotion of plaque development [49] . miR-126 shuttled by endothelial cell (EC) exosomes showed ability to directly accelerate re-endothelialization [50] . Thus, its repressed expression in exosomes from diabetic patients and EC cells cultured under hyperglycemic conditions [50] could explain its importance to cell and tissue preservation. miR-146 was shown to contribute to reduced atherogenesis [51] , whereas miR-302a inhibition led to reduced atherosclerotic plaque size, increased plaque stability, and reduced inflammation. miR-26a was shown to counteract endothelial cell apoptosis [52] . A study of ECs cultured in high-glucose environment showed increased production of miR-503, which transferred to vascular pericytes and resulted in their impaired migration and proliferative behavior [53] . These studies demonstrate how only a few components of the exosomal cargo can have a profound impact on the development and progression of a pathology.
Beyond the hostile high-glucose environment, another stress stimulus is Bshear stress,^which has been identified as a physiological contributor to altered exosome and exosomal cargo shedding and information exchange by ECs, identifying them as potential therapeutic targets for modulating the Fig. 2 Applications of exosomes in cardiovascular health and disease: exosomes can be isolated from patients' biofluids to identify biomarkers. Exosome can be used as a cargo to carry therapeutic regimens. Exosomemediated intracellular communication between different cardiovascular cells (cardiomyocytes, endothelial cells, and fibroblasts) can be studied to further understand cardiovascular disease. Stem cell-derived exosomes can be used as a therapeutic regimen for cardiovascular disease progression of atherosclerosis. Their impact on atherosclerotic development involves increased endothelial inflammation, higher permeability of the endothelial barrier, cell cycle arrest, and enhanced monocyte adhesion to the endothelium [54, 55] . Conversely, Essandoh K et al. [56] show that blocking of exosome release can be protective against sepsis-induced inflammatory response and cardiac dysfunction.
Acute myocardial infarction (MI) is characterized by a sudden occlusion of the coronary vessel and results in cardiac cell death due to ischemia. Studies investigating potential therapies revealed that exosomes released from cardiac progenitor cells (CPCs) and embryonic stem cells (ESCs) have the potential to regulate and enhance cardiac regeneration capabilities [57] . Studies reported that CPCs secrete pro-regenerative exosomes during hypoxia and thus contribute to preserved cardiac output after MI as well as contribute to decreased profibrotic gene expression in activated fibroblasts. These findings indicate that hypoxia triggers a regenerative response, during which CPCs transfer antifibrotic miRNAs to fibroblasts, counteract cardiomyocyte apoptosis, and enhance angiogenesis thus preserving LV ejection fraction [15, 30] . Additionally, Lai et al. characterized mesenchymal stem cellderived exosome treatment applied to the ischemia reperfusion injury model and reported preserved cardiac function and decreased infarct size [58] Cardiosphere-derived exosomes have also been shown to enhance the proliferative and angiogenic effects of cardiomyocytes [31] .
Cardiac remodeling due to prolonged stress due to coronary artery disease, atrial fibrillation, and hypertension leads to hypertrophy of cardiomyocytes, fibrosis of the heart muscle, and ultimate heart failure. The fibroblastsecreted exosomes enriched in miR-21 have been shown to act as paracrine signaling mediators inducing cardiomyocyte hypertrophy [13] .
In [59] , miR-590 and miR199a have been shown to reprogram adult CMs to proliferate. Exosomes have been described to promote angiogenesis, transform fibroblasts to myofibroblasts, and transform mesenchymal stem cells to myofibroblasts. In the heart, exosomes have been documented to play important roles in the maintenance of cardiac homeostasis as well as in the pathogenesis of heart disease [1, 13, 46, 60] . These reports identify exosome-based intercellular cargo exchange as a fundamental contributor to the preservation and/or detriment of the heart muscle post ischemic injury, thus suggesting an enormous interventional potential by regulating the exchange miRNA based communication.
Challenges and Problems
Despite a large body of evidence suggesting that exosomebased cell communication feature could be exploited for both diagnostic and therapeutic purposes, the mechanisms of cargo selection, cargo loading, and vesicle targeting are still largely unknown. Most of all, however, the type of active molecules contributing to recipient cell's alteration of physiology have to be investigated. Despite the functional impact of exosomes on cell homeostasis, proliferation, senescence, transformation, etc. the open question remains of specifically which exosome-contained molecules influence their recipient cells.
miRNAs are so far the most studied cargo molecules. Considering a large number and variety of protein, lipid, and nucleic acid components trafficked via exosomes, it is likely that a combination of these components could have a more potent influence on cells as they might act in concert and affect multiple a multitude of signaling pathways.
Conclusions
The capacity of exosomes in circulation to maintain stability and provide protection for a wide range of cargo including mRNAs, miRNAs, and a variety of other less investigated biomolecules such as proteins, enzymes, molecular chaperones and signaling molecules [6] , makes this subset of extracellular microvesicles a promising therapeutic tool for treatment of cardiovascular and other pathologies. Being biocompatible, low immunogenic, and having the ability to permeate through biological barriers [61] allows for distribution of viable and effective cargo and gives hope for their potential application as vehicles for delivery of therapeutics. Continued investigations will contribute to increased understanding of spatiotemporal relations of exosomal synthesis and release and targeting and hold promise for the development of new cellfree and individualized, patient-specific therapies of the future.
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